• Explore /
  • Poster
  • / Evaluation of prognostic and predictive values of bespoke circulating tumor DNA assay in patients with advanced epithelial ovarian cancer.

Evaluation of prognostic and predictive values of bespoke circulating tumor DNA assay in patients with advanced epithelial ovarian cancer.

Abstract Poster

Authors

null

Hao Wen

Department of Gynecologic Oncology, Fudan University Shanghai Cancer Center, Shanghai, China

Hao Wen , Jing Xu , Yun Chen , Zheng Feng , Yanping Zhong , Lei Sun , Lin Chen , Shida Zhu , Xiaohua Wu

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gynecologic Cancer

Track

Gynecologic Cancer

Sub Track

Ovarian Cancer

Clinical Trial Registration Number

NCT05446545

Citation

J Clin Oncol 42, 2024 (suppl 16; abstr 5570)

DOI

10.1200/JCO.2024.42.16_suppl.5570

Abstract #

5570

Poster Bd #

441

Abstract Disclosures

Similar Posters

First Author: Bonnita Werner

Poster

2017 ASCO Annual Meeting

Circulating free DNA and circulating tumor cells as new serum biomarkers in advanced ovarian cancer.

Circulating free DNA and circulating tumor cells as new serum biomarkers in advanced ovarian cancer.

First Author: Jeronimo Martinez garcia

First Author: Beihua Kong

First Author: Meredith Pelster